Results

Total Results: 46 records

Showing results for "anticoagulant prophylaxis".

1. Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
   August 06, 2010 - Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction; prophylaxis … via permanent placement in the vena cava in the following situations: pulmonary thromboembolism when anticoagulants … via permanent placement in the vena cava in the following situations: pulmonary thromboembolism when anticoagulants … embolism via placement in the vena cava in the following situations: pulmonary thromboembolism when anticoagulants … embolism via placement in the vena cava in the following situations: pulmonary thromboembolism when anticoagulants

2. Evidence Report on the (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
   February 01, 2008 - Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction; prophylaxis … in the vena cava in the following conditions: venous thrombosis or pulmonary thromboembolism when anticoagulants … permanent placement in the vena cava in the following situations: pulmonary thromboembolism when anticoagulants … VTE.mp 32. venous thrombosis/ 33. venous thrombos*.mp 34. clot.mp 35. or/20-34 36. anticoagulants … IVC.mp 101. or/97-100 102. 75 or 96 or 101 103. 19 and 35 and 102 SCOPUS ((((ALL(anticoagulants

3. Evidence Report on the (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
   February 01, 2008 - Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction; prophylaxis … in the vena cava in the following conditions: venous thrombosis or pulmonary thromboembolism when anticoagulants … permanent placement in the vena cava in the following situations: pulmonary thromboembolism when anticoagulants … VTE.mp 32. venous thrombosis/ 33. venous thrombos*.mp 34. clot.mp 35. or/20-34 36. anticoagulants … IVC.mp 101. or/97-100 102. 75 or 96 or 101 103. 19 and 35 and 102 SCOPUS ((((ALL(anticoagulants

4. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research-protocol
   January 12, 2012 - will also evaluate the use of antiplatelet agents, such as aspirin and clopidogrel, as well as the anticoagulant … Dabigatran is a newly developed oral anticoagulant that directly inhibits thrombin; it has been approved … The concern about anticoagulant thromboprophylaxis in this population is progression of intracranial … optimal threshold of thrombocytopenia and the prolonged INR value at which bleeding increases with anticoagulant … Current ACCP guidelines recommend that anticoagulant medications that bioaccumulate should be avoided

5. Evidence-based Practice Center Systematic Review Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
   March 01, 2011 - will also evaluate the use of antiplatelet agents, such as aspirin and clopidogrel, as well as the anticoagulant … Dabigatran is a newly developed oral anticoagulant that directly inhibits thrombin; it has been approved … The concern about anticoagulant thromboprophylaxis in this population is progression of intracranial … Current ACCP guidelines recommend that anticoagulant medications that bioaccumulate should be avoided … [tiab] prophyla*[tiab] Pulmonary embolism[tiab] Anticoagulant[tiab] prevention and control[subheading

6. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
   March 01, 2012 - Routine perioperative anticoagulant prophylaxis has been suggested to reduce PE risk, but must be tempered … agents used in study context 7) Develop Manual of Procedures to ensure standardization of data collection … Include relevant data from studies on additional prophylaxis anticoagulants, specifically oral Factor … Tim Schiro General KQ 2: The answer to this question may improve VTE prophylaxis and anticoagulant safety … (with or without a contraindication to anticoagulant TP).

7. Untitled (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
   February 17, 2016 - A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … Available drugs are anticoagulants that lower the likelihood that blood clots. … or venous thromboembol* or VTE or "Venous Thrombosis"[Mesh] or venous thrombos* or clot AND "Anticoagulants … Thromboembolism or venous thromboembol* or VTE or Venous Thrombosis or venous thrombos* or clot AND Anticoagulants … Thromboembolism or venous thromboembol* or VTE or Venous Thrombosis or venous thrombos* or clot AND Anticoagulants

8. Evidence-based Practice Center Systematic Review Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
   December 11, 2012 - Anticoagulant agents. … agents are currently recommended for managing patients who present with UA/NSTEMI. … Additionally, the introduction of a number of newer oral antiplatelet and anticoagulant agents will … /kg For CrCl <30 ml/min: 1 mg/kg Every 12 hr Daily Subcutaneous Approved Indicated for prophylaxis … Dalteparin Eisai Inc. 120 IU/kg (max 10,000 IU) Every 12 hr Subcutaneous Approved Indicated for prophylaxis

9. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research-protocol
   December 13, 2012 - Anticoagulant agents. … agents are currently recommended for managing patients who present with UA/NSTEMI. … Additionally, the introduction of a number of newer oral antiplatelet and anticoagulant agents will make … Enoxaparin Sanofi-Aventis US LLC 1 mg/kg Every 12 hr Subcutaneous Approved Indicated for prophylaxis … 3 mg 4 mg 5 mg 6 mg 7.5 mg 10 mg Daily Oral Approved Indicated for the prophylaxis

10. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
    January 30, 2012 - These compounds create an anticoagulant effect by inhibiting the y-carboxylation of vitamin K-dependent … New anticoagulants are challenging the predominance of VKA for stroke prophylaxis in AF. … Am Heart J 2010;159(3):331-9 24 ) The evolution of the newer anticoagulation agents investigated in … example, in patients with AF undergoing surgery or percutaneous procedures, the duration of holding anticoagulant … Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

11. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
    January 30, 2012 - These compounds create an anticoagulant effect by inhibiting the у-carboxylation of vitamin K-dependent … New anticoagulants are challenging the predominance of VKA for stroke prophylaxis in AF. … Am Heart J 2010;159(3):331-924) The evolution of the newer anticoagulation agents investigated in … example, in patients with AF undergoing surgery or percutaneous procedures, the duration of holding anticoagulant … Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

12. VTE Surveillance Assessment_49_low_SPI (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
    December 01, 2012 - DVT and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the … 1) 225 223 use cctr (0) *************************** SCOPUS: Major Line: 4 (ALL(anticoagulants … ) OR LIMIT-TO(PUBYEAR, 2012) OR LIMIT-TO(PUBYEAR, 2011)) Total: 13 -- Line: 1 ALL(anticoagulants … (LIMIT-TO(PUBYEAR, 2012) OR LIMIT-TO(PUBYEAR, 2011) OR LIMIT-TO(PUBYEAR, 2010)) 23 18 (((ALL(anticoagulants … and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the percentage

13. Vascular Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/vascular-diseases
    August 16, 2010 - Atherosclerotic Plaque Technical Brief Archived August 16, 2010 Venous Thromboembolism Prophylaxis … Orthopedic Surgery Systematic Review Archived March 13, 2012 Venous Thromboembolism Prophylaxis … Review Archived September 25, 2013 Systematic Review Update of Venous Thromboembolism Prophylaxis … Report January 29, 2014 Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis … ) Reports on Future Research Research Report June 10, 2011 Antiplatelet and Anticoagulant

14. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
    July 27, 2023 - What are the frequency and severity of harms associated with anticoagulant use in the inpatient and … What patient safety measures or indicators have been used to examine the harm associated anticoagulant … treatment and prophylaxis of venous thromboembolism in patients with cancer. … : focus on new anticoagulant agents. … Harms Due to Anticoagulants.

15. Disposition of Comments Report for Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
    May 29, 2013 - including KQ1 Reviewer 7 Discussion For KQ2, a double-blind RCT of early vs delayed initiation of anticoagulant … Discussion For KQ7, I don’t agree with the recommendation to do RCTs of weight-based or BMI- based anticoagulant … This data will provide the basis for proof of concept for trials with the new oral anticoagulants. … burns, antiplatelet therapy, renal failure, and bariatric surgery is clear to me since the risks of anticoagulant … While this is not a method of prophylaxis it certainly is part of a comprehensive VTE prophylaxis program

16. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - New anticoagulants are challenging the predominance of VKAs for stroke prophylaxis in AF. … The evolution of newer anticoagulation agents, like those studied in the large trials above, as well … agents compared with warfarin. … agents compared with warfarin (low strength of evidence). … agents (dabigatran, rivaroxaban, apixaban).

17. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
    June 22, 2017 - not take into account all of the serious events that can occur as a result of administration of anticoagulation … agents because the vast majority of the selected studies carry significant exclusion criteria not … agents for prevention of VTE following total joint arthroplasty came up with different conclusions … I have 2 suggestions: In sections relating to anticoagulant dose, a distinction is made between … Potent anticoagulants are associated with a higher all-cause mortality rate after THA and TKA [20]

18. Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research
    May 29, 2013 - 2013 Systematic Review Sep. 12, 2013 Disposition of Comments Report Pharmacologic and Mechanical Prophylaxis … systematically review the comparative effectiveness and safety of pharmacological and mechanical methods of prophylaxis

19. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable Cardiovascular Devices (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-cardio-dental.pdf
    July 01, 2023 - In the last 15 years, NICE, in the UK, has recommended ceasing all such prophylaxis,31 while others … Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective … Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures. … Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis … IE Prophylaxis: Recommendation Prophylaxis against IE is reasonable before dental procedures that involve

20. Blood-Clots-Hip-Knee-Surgery Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
    March 01, 2012 - Such strategies include pharmacological (antiplatelet, anticoagulant) and mechanical modalities that … DVT and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the … KQ 4: Providing pharmacologic prophylaxis versus no prophylaxis has a better comparative balance of … There is high evidence that pharmacologic prophylaxis versus no prophylaxis significantly decreased … There is low evidence that pharmacologic prophylaxis versus no prophylaxis significantly decreases